StockVS

PACS Group, Inc. (PACS) 股票分析

医疗保健

PACS Group, Inc.

$38.87

+$1.12 (+2.97%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

PACS Group, Inc. operates a network of skilled nursing facilities, assisted living facilities, senior care, and independent living facilities across the United States, while also engaging in the acquisition, ownership, and leasing of healthcare-related properties. The company is positioned within the Healthcare sector, specifically under the Medical Care Facilities industry, which implies a focus on providing essential long-term care services to an aging demographic. PACS Group holds a market capitalization of $5.56 billion and generates annual revenue of $5.29 billion, supported by a workforce of 47,455 employees. These valuation and revenue figures indicate that the company is a significant player in the medical care infrastructure, possessing substantial scale that allows it to leverage its operational footprint across multiple geographic regions.

财务健康

The company reported revenue of $5.29 billion for the trailing twelve months, with a net income of $191.54 million and EBITDA of $365.26 million. The substantial gap between the $5.29 billion in revenue and the $191.54 million in net income reveals a cost structure characterized by significant operating expenses, including overhead, labor, and regulatory compliance costs inherent to the skilled nursing sector. Free cash flow stands at $241.90 million, which provides the company with financial flexibility to fund capital expenditures, manage debt obligations, or pursue strategic acquisitions without relying solely on external financing. Gross margin is 15.5%, operating margin is 7.0%, and profit margin is 3.6%; these levels indicate that for every dollar of revenue, the company retains a relatively small portion as bottom-line profit after covering the high fixed costs associated with running medical facilities. The balance sheet shows $197.02 million in cash against $3.60 billion in debt, resulting in a debt-to-equity ratio of 377.77%, which suggests the company is highly leveraged and relies heavily on borrowed capital to finance its asset base. Current ratio is 1.07, indicating that the company has just enough current assets to cover its short-term liabilities, suggesting a tight but manageable liquidity position. Return on Equity is 23.0% while Return on Assets is 3.6%, revealing that management is effective at generating high returns on shareholders' invested capital, though the return on the total asset base is lower due to the high leverage and the capital-intensive nature of the facility ownership model.

估值评估

The trailing twelve-month P/E ratio is 29.00, while the forward P/E is 14.99; this significant difference implies that the market expects earnings to grow substantially in the future, as the forward multiple prices in anticipated performance improvements that are not yet reflected in the current earnings. The price-to-book ratio is 5.85, which indicates that the market values the company at a substantial premium over its tangible book value, suggesting high expectations for future growth or intangible asset value not fully captured on the balance sheet. Alternative valuation metrics include a price-to-sales ratio of 1.05 and an EV/EBITDA of 24.55, which suggest that investors are willing to pay a moderate multiple relative to revenue but a higher multiple relative to earnings before interest, taxes, depreciation, and amortization. The 52-week high is $43.08 and the 52-week low is $7.50; without a specific current price in the provided facts, the trading range demonstrates extreme volatility, with the stock capable of trading anywhere within this wide band relative to its historical extremes. Beta is listed as N/A, meaning volatility data relative to the broader market is not available in the current dataset to assess price sensitivity to market movements.

Growth & Income

Revenue growth year-over-year is 12.4%, and earnings growth year-over-year is 57.2%; these figures indicate that earnings are growing significantly faster than revenue, which implies improving operational efficiency, margin expansion, or a favorable mix of higher-margin services within the portfolio. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, indicating that the company reinvests all of its earnings back into the business to fund expansion, facility upgrades, or debt reduction rather than distributing cash to shareholders. This reinvestment strategy supports the high earnings growth rate by allowing the company to scale its operations and capture more market share in the competitive senior care sector. Overall, the growth and income profile is defined by aggressive earnings expansion without shareholder payouts, prioritizing capital allocation toward growth initiatives over current income generation for investors.

同行比较

PACS Group, Inc. (PACS) 在医疗保健设施行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
PACS Group, Inc. PACS $5.97B 24.4
HCA Healthcare, Inc. HCA $87.05B 13.5
Tenet Healthcare Corporation THC $15.19B 9.2
DaVita Inc. DVA $12.55B 18.8

医疗保健设施行业平均市盈率为28.6倍。PACS Group, Inc.的市盈率为24.4。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于PACS Group, Inc.

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

公司简介以英文显示。

访问官网 →

关键指标

市值
$5.97B
市盈率
24.35
52周最高
$43.08
52周最低
$7.50
平均成交量
884.15K
Beta系数
-0.03

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NYSE
国家
United States
员工数
47,455